Pacific Biosciences of California, Inc. (PACB)
NASDAQ · Healthcare
Pacific Biosciences of California, Inc. Revenue 2009–2025
Pacific Biosciences of California, Inc. annual/quarterly revenue history and growth rate from 2009 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Pacific Biosciences of California, Inc. revenue for the quarter ending March 31, 2026 was 37.2 M, a 0.07% increase year-over-year.
- Pacific Biosciences of California, Inc. revenue for the twelve months ending March 31, 2026 was 152.5 M, a 10.52% decrease year-over-year.
- Pacific Biosciences of California, Inc. annual revenue for 2025 was 160.0 M, a 3.89% increase from 2024.
- Pacific Biosciences of California, Inc. annual revenue for 2024 was 154.0 M, a 23.19% decrease from 2023.
- Pacific Biosciences of California, Inc. annual revenue for 2023 was 200.5 M, a 56.29% increase from 2022.
- Pacific Biosciences of California, Inc. annual revenue for 2022 was 128.3 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Pacific Biosciences of California, Inc. Market Cap — FAQ
Pacific Biosciences of California, Inc. (PACB) market cap over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PACB's market cap history?
The chart and table above show Pacific Biosciences of California, Inc.'s market cap by year and by quarter, including the growth rate.